TD Cowen analyst Josh Jennings has maintained their bullish stance on CERS stock, giving a Buy rating on May 3. Josh Jennings has given his ...

CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter ...

Q1 2024 Earnings Call Transcript May 2, 2024 Cerus Corporation misses on earnings expectations. Reported EPS is $-0.0532 EPS, ...

A new biotech is coming out of stealth with $16 million to develop cell therapies for solid cancers — an area where scientists have had limited success. OverT Bio (pronounced ...

Cerus Corp ( NASDAQ:CERS) released its 8-K filing on May 2, 2024, detailing its financial performance for the first quarter ended March 31, 2024. The company, a leader in blood transfusion safety with ...

CONCORD, Calif. (AP) — CONCORD, Calif. (AP) — Cerus Corp. (CERS) on Thursday reported a loss of $9.7 million in its first quarter. On a per-share basis, the Concord, California-based company said it ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Explore key financial outcomes and strategic insights from Cerus Corp's first quarter of 2024, reflecting robust product sales and operational advancements.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Joint (JYNT – Research Report) and Cerus (CERS – Research Report). Joint (JYNT) In a report released today, Jeremy ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...